Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,798 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association of Sacubitril/Valsartan versus Valsartan with Blood Pressure Changes, and Symptomatic Hypotension: The PARAGLIDE-HF Trial.
Fudim M, Cyr DD, Ward JH, Hernandez AF, Lepage S, Morrow DA, Sharma K, Claggett BL, Starling RC, Velazquez EJ, Williamson KM, Desai AS, Zieroth S, Solomon SD, Braunwald E, Mentz RJ; PARAGLIDE-HF Investigators. Fudim M, et al. Among authors: solomon sd. J Card Fail. 2024 May 25:S1071-9164(24)00187-8. doi: 10.1016/j.cardfail.2024.04.030. Online ahead of print. J Card Fail. 2024. PMID: 38802053
The relative vaccine effectiveness of high-dose vs standard-dose influenza vaccines in preventing hospitalization and mortality: A meta-analysis of evidence from randomized trials.
Skaarup KG, Lassen MCH, Modin D, Johansen ND, Loiacono MM, Harris RC, Lee JKH, Dufournet M, Vardeny O, Peikert A, Claggett B, Solomon SD, Jensen JUS, Biering-Sørensen T. Skaarup KG, et al. Among authors: solomon sd. J Infect. 2024 May 23;89(1):106187. doi: 10.1016/j.jinf.2024.106187. Online ahead of print. J Infect. 2024. PMID: 38795774 Free article.
Balcinrenone plus dapagliflozin in patients with heart failure and chronic kidney disease: Results from the phase 2b MIRACLE trial.
Lam CSP, Køber L, Kuwahara K, Lund LH, Mark PB, Mellbin LG, Schou M, Ely Pizzato P, Gabrielsen A, Gasparyan SB, Ghiretti A, Hartleib-Geschwindner J, Housler GJ, Fanti P, Leonsson-Zachrisson M, McMurray JJV, Solomon SD; MIRACLE Study Investigators. Lam CSP, et al. Among authors: solomon sd. Eur J Heart Fail. 2024 May 23. doi: 10.1002/ejhf.3294. Online ahead of print. Eur J Heart Fail. 2024. PMID: 38783712
Racial, Ethnic and Socioeconomic Diversity and Outcomes of Patients with Graft-versus-Host Disease: A CIBMTR Analysis.
Farhadfar N, Rashid N, Chen K, DeVos JD, Wang T, Ballen KK, Beitinjaneh A, Bhatt VR, Hamilton BK, Hematti P, Gadalla SM, Solomon SR, El Jurdi N, Lee CJ, MacMillan ML, Rangarajan HG, Schoemans HM, Sharma A, Spellman SR, Wingard JR, Lee SJ. Farhadfar N, et al. Among authors: solomon sr. Blood Adv. 2024 May 22:bloodadvances.2024013074. doi: 10.1182/bloodadvances.2024013074. Online ahead of print. Blood Adv. 2024. PMID: 38776400
A real-world assessment of stage I lung cancer through electronic nose technology.
Rocco G, Pennazza G, Tan KS, Vanstraelen S, Santonico M, Corba RJ, Park BJ, Sihag S, Bott MJ, Crucitti P, Isbell JM, Ginsberg MS, Weiss H, Incalzi RA, Finamore P, Longo F, Zompanti A, Grasso S, Solomon SB, Vincent A, McKnight A, Cirelli M, Voli C, Kelly S, Merone M, Molena D, Gray K, Huang J, Rusch VW, Bains MS, Downey RJ, Adusumilli PS, Jones DR. Rocco G, et al. Among authors: solomon sb. J Thorac Oncol. 2024 May 16:S1556-0864(24)00211-9. doi: 10.1016/j.jtho.2024.05.006. Online ahead of print. J Thorac Oncol. 2024. PMID: 38762120
Effect of the administration route on the hemostatic efficacy of tranexamic acid in patients undergoing short-segment posterior lumbar interbody fusion: a systematic review and meta-analysis.
Hatter MJ, Pennington Z, Hsu TI, Shooshani T, Yale O, Pooladzandi O, Solomon SS, Picton B, Ramanis M, Brown NJ, Hashmi S, Lee YP, Bhatia N, Pham MH. Hatter MJ, et al. Among authors: solomon ss. J Neurosurg Spine. 2024 May 17:1-12. doi: 10.3171/2024.2.SPINE23779. Online ahead of print. J Neurosurg Spine. 2024. PMID: 38759242
Effect of dapagliflozin in patients with diabetes and heart failure with mildly reduced or preserved ejection fraction according to background glucose-lowering therapy: A pre-specified analysis of the DELIVER trial.
Lassen MCH, Ostrominski JW, Inzucchi SE, Claggett BL, Kulac I, Jhund P, de Boer RA, Hernandez AF, Kosiborod MN, Lam CSP, Martinez FA, Shah SJ, Desai AS, Petersson M, Langkilde AM, Docherty KF, McMurray JJV, Solomon SD, Vaduganathan M. Lassen MCH, et al. Among authors: solomon sd. Eur J Heart Fail. 2024 May 15. doi: 10.1002/ejhf.3269. Online ahead of print. Eur J Heart Fail. 2024. PMID: 38745498
3,798 results